These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 19001163

  • 1. Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis.
    Khaleeli Z, Altmann DR, Cercignani M, Ciccarelli O, Miller DH, Thompson AJ.
    Arch Neurol; 2008 Nov; 65(11):1454-9. PubMed ID: 19001163
    [Abstract] [Full Text] [Related]

  • 2. Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis.
    Ge Y, Grossman RI, Udupa JK, Babb JS, Kolson DL, McGowan JC.
    AJNR Am J Neuroradiol; 2001 Mar; 22(3):470-5. PubMed ID: 11237968
    [Abstract] [Full Text] [Related]

  • 3. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.
    Bakshi R, Neema M, Healy BC, Liptak Z, Betensky RA, Buckle GJ, Gauthier SA, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury SJ, Guttmann CR, Weiner HL.
    Arch Neurol; 2008 Nov; 65(11):1449-53. PubMed ID: 19001162
    [Abstract] [Full Text] [Related]

  • 4. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O, Gouveia A, Batista S, Moura C, Machado E.
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [Abstract] [Full Text] [Related]

  • 5. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M.
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [Abstract] [Full Text] [Related]

  • 6. Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.
    Fisniku LK, Altmann DR, Cercignani M, Tozer DJ, Chard DT, Jackson JS, Miszkiel KA, Schmierer K, Thompson AJ, Miller DH.
    Mult Scler; 2009 Jun; 15(6):668-77. PubMed ID: 19435751
    [Abstract] [Full Text] [Related]

  • 7. Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS.
    Tur C, Khaleeli Z, Ciccarelli O, Altmann DR, Cercignani M, Miller DH, Thompson AJ.
    J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):423-8. PubMed ID: 20974648
    [Abstract] [Full Text] [Related]

  • 8. Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis.
    Bieniek M, Altmann DR, Davies GR, Ingle GT, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH.
    J Neurol Neurosurg Psychiatry; 2006 Sep; 77(9):1036-9. PubMed ID: 16793860
    [Abstract] [Full Text] [Related]

  • 9. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
    Samson RS, Cardoso MJ, Muhlert N, Sethi V, Wheeler-Kingshott CA, Ron M, Ourselin S, Miller DH, Chard DT.
    Mult Scler; 2014 Sep; 20(10):1322-30. PubMed ID: 24552746
    [Abstract] [Full Text] [Related]

  • 10. Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis.
    Khaleeli Z, Sastre-Garriga J, Ciccarelli O, Miller DH, Thompson AJ.
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1076-82. PubMed ID: 17287235
    [Abstract] [Full Text] [Related]

  • 11. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G, Colasanti A, Rabiner EA, Gunn RN, Malik O, Ciccarelli O, Nicholas R, Van Vlierberghe E, Van Hecke W, Searle G, Santos-Ribeiro A, Matthews PM.
    Brain; 2017 Nov 01; 140(11):2927-2938. PubMed ID: 29053775
    [Abstract] [Full Text] [Related]

  • 12. Brain atrophy and lesion load predict long term disability in multiple sclerosis.
    Popescu V, Agosta F, Hulst HE, Sluimer IC, Knol DL, Sormani MP, Enzinger C, Ropele S, Alonso J, Sastre-Garriga J, Rovira A, Montalban X, Bodini B, Ciccarelli O, Khaleeli Z, Chard DT, Matthews L, Palace J, Giorgio A, De Stefano N, Eisele P, Gass A, Polman CH, Uitdehaag BM, Messina MJ, Comi G, Filippi M, Barkhof F, Vrenken H, MAGNIMS Study Group.
    J Neurol Neurosurg Psychiatry; 2013 Oct 01; 84(10):1082-91. PubMed ID: 23524331
    [Abstract] [Full Text] [Related]

  • 13. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
    van Walderveen MA, Lycklama A Nijeholt GJ, Adèr HJ, Jongen PJ, Polman CH, Castelijns JA, Barkhof F.
    Arch Neurol; 2001 Jan 01; 58(1):76-81. PubMed ID: 11176939
    [Abstract] [Full Text] [Related]

  • 14. CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis.
    Marastoni D, Magliozzi R, Bolzan A, Pisani AI, Rossi S, Crescenzo F, Montemezzi S, Pizzini FB, Calabrese M.
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov 01; 8(6):. PubMed ID: 34588298
    [Abstract] [Full Text] [Related]

  • 15. Gray matter atrophy is related to long-term disability in multiple sclerosis.
    Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, Thompson AJ, Miller DH.
    Ann Neurol; 2008 Sep 01; 64(3):247-54. PubMed ID: 18570297
    [Abstract] [Full Text] [Related]

  • 16. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.
    Sastre-Garriga J, Ingle GT, Chard DT, Ramió-Torrentà L, McLean MA, Miller DH, Thompson AJ.
    Arch Neurol; 2005 Apr 01; 62(4):569-73. PubMed ID: 15824254
    [Abstract] [Full Text] [Related]

  • 17. Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis.
    Sestito C, Leurs CE, Steenwijk MD, Brevé JJP, Twisk JWR, Wilhelmus MMM, Drukarch B, Teunissen CE, van Dam AM, Killestein J.
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul 01; 8(4):. PubMed ID: 33906937
    [Abstract] [Full Text] [Related]

  • 18. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.
    Mult Scler; 2009 Feb 01; 15(2):204-11. PubMed ID: 18987104
    [Abstract] [Full Text] [Related]

  • 19. Cervical cord lesion load is associated with disability independently from atrophy in MS.
    Kearney H, Altmann DR, Samson RS, Yiannakas MC, Wheeler-Kingshott CA, Ciccarelli O, Miller DH.
    Neurology; 2015 Jan 27; 84(4):367-73. PubMed ID: 25540312
    [Abstract] [Full Text] [Related]

  • 20. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.
    Rovaris M, Judica E, Sastre-Garriga J, Rovira A, Sormani MP, Benedetti B, Korteweg T, De Stefano N, Khaleeli Z, Montalban X, Barkhof F, Miller DH, Polman C, Thompson AJ, Filippi M.
    Mult Scler; 2008 May 27; 14(4):455-64. PubMed ID: 18208869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.